ÅǸ޴º
Á¦¸ñ | REACH-2: First biomarker-based anti-angiogenic therapy in patients with advanced hepatocellular carcinoma. Chinese Clinical Oncology 2020 (Editorial commentary) | µî·ÏÀÏ | 20200922 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Chon HJ and Kim C. REACH-2: First biomarker-based anti-angiogenic therapy in patients with advanced hepatocellular carcinoma. Chinese Clinical Oncology 2020 (Editorial commentary)
|
Copyright ¨Ï chamc, All rights reserved.